FREDERICK, MD, July 12, 2018 (GLOBE NEWSWIRE) — BioElectronics Corporation (OTC PINK: BIEL), www.bielcorp.com is pleased to announce that a Traditional 510(k) Premarket Notification for ActiPatch® was filed today with the U.S. Food and Drug Administration (FDA). The market clearance requested was “over-the-counter adjunctive use in the treatment of musculoskeletal pain”. While ActiPatch is already FDA-cleared for … Continue Reading
Archives
BioElectronics to Showcase Products at World’s Largest Medical Tradeshow
FREDERICK, MD–(Marketwired – Nov 9, 2017) – BioElectronics Corporation (OTC PINK: BIEL) is the maker of advanced, non-prescription pain management medical devices. The company announced today that it will showcase its range of pain and inflammation reduction products at MEDICA 2017 in Germany, dubbed as the leading international tradeshow for the medical industry. The company will … Continue Reading
BioElectronics Corporation Announces US FDA OTC Clearances For Drug-free ActiPatch® Musculoskeletal Pain Therapy
FREDERICK, MD, USA, February 5, 2017 — BioElectronics Corporation (OTC Pink: BIEL), the maker of wearable pain therapy devices, announced today that it has received over-the-counter use market clearance from the US FDA for ActiPatch® for the adjunctive treatment of musculoskeletal pain related to (1) plantar fasciitis of the heel; and (2) osteoarthritis of the … Continue Reading